Medindia
Medindia LOGIN REGISTER
Advertisement

Reportlinker Adds Molecular Diagnostics - A World Market Review

Wednesday, December 2, 2009 General News
Advertisement


NEW YORK, Dec. 1 Reportlinker.com announces that a new market research report is available in its catalogue:

Molecular Diagnostics - A World Market Review
Advertisement

http://www.reportlinker.com/p0164231/Molecular-Diagnostics---A-World-Market-Review.html

Molecular diagnostics market is being driven by several growth factors that include the need for automated and easy-to-handle techniques, which combine optimized sample preparation, analysis, and data evaluation, and the growing availability of molecular diagnostic tests for monitoring the therapeutic efficacy of expensive drugs. Additionally, the requirement of swift diagnoses techniques that would diagnose disease condition and medical disorders quickly and offer a strong and consistent tool for quick therapy decisions represents the other key factor. In terms of technological push, genomics and proteomics are the major drivers of the molecular diagnostic market. Nanobiotechnology and biochips are of key interest to the molecular diagnostics market.
Advertisement

Demand for molecular diagnostics and gene detection products is determined by the volume of tests performed in clinical labs, which continues to be miniscule in comparison to large battery of conventional diagnostic lab tests. However, provoked by the rate at which molecular tests is growing, companies are investing heavily in molecular diagnostics and gene detection systems to realize the potential in the offing.

These and other market data and trends are presented in "Molecular Diagnostics: A World Market Review" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

MOLECULAR DIAGNOSTICS BMR-1031

CONTENTS

1. METHODOLOGY 1

Study Reliability and Reporting Limitations 1

Disclaimers 2

Quantitative Techniques & Reporting Level 3

2. INDUSTRY OVERVIEW 4

Global Market Outlook 4

Molecular Diagnostics - The Fastest Growing Medical

Diagnostic- Technology 4

New Applications Hold Promising Potential 5

Automated Systems - Prime Target 5

Infectious Disease Testing Drives the Diagnostics Market 5

The Future in Store 6

3. A REVIEW OF MEDICAL DIAGNOSTICS MARKET 7

Clinical Diagnostics Industry - Trends and Tendencies 7

Diagnostic Tests - Classification 8

Nucleic Acid Diagnostics Market - An Overview 9

Molecular Diagnostics - Growth Drivers 11

Molecular Diagnostics - A Replacement and Enabling Technology 11

Molecular Diagnostics for Lymphoid Malignancies 12

4. COMPETITIVE DYNAMICS IN THE MOLECULAR DIAGNOSTICS MARKET 13

Key Players and Their Technologies 13

The Top Tier 13

Mid-Sized and Small Companies 13

5. MARKET TRENDS & ISSUES 14

Market Consolidations on the Way to Integrate In Vivo and In

Vitro Diagnostics 14

Global Molecular Diagnostics on High Growth Curve 15

Pharmaceutical Firms Carving Their Niche in Molecular

Diagnostic Market 15

Towards Tailoring the Right Treatment for the Right Disease 15

Disease-Specific Molecular Diagnostics to Deliver Improved

Clinical Outcomes 16

Molecular Diagnostics and Intellectual Property 16

Business Opportunities in the Offing 16

Challenges Facing the Molecular Diagnostic Market 17

Medical Training and Practice Challenges 17

Shortcomings to Overcome 18

Limited Reimbursements by Third Party Payers - A Stumbling Block 18

Hurdles All the Way for Companies Eyeing Molecular Diagnostics 19

Product Marketing - Key to Commercial Success 20

Integration of Molecular Diagnostics into Therapeutics 20

Molecular Diagnostics - Moving from Centralization to

Decentralization 20

Migrating to Decentralized Format 21

Going Ahead with Decentralization 22

6. PRODUCT FACTS 22

Infectious Diseases Testing 22

Pharmacogenomics 23

Cancer Screening 23

7. CORPORATE DEVELOPMENTS 24

Vermillion, Johns Hopkins Ink Agreements to Develop Molecular

Diagnostic-Tests 24

Beckman Coulter Inks Licensing Agreements with National

University of Ireland 24

Roche Takes Over BioVeris 24

Siemens Acquires Dade Behring 24

DiagnoCure Acquires Catalyst Oncology 25

Burrill & Co Takes over Expression Diagnostics 25

Solis Acquires Bertrand 25

ParagonDx LLC Purchases Gentris Diagnostics 25

Beckman Collaborates to Discover CVD Symptoms 25

Exiqon to Take over Oncotech 26

Roche to Acquire Ventana 26

Qiagen Merges with Digene 26

Qiagen & Bio One Capital Collaborates 26

AGT & MAL Signs MoU 26

Qiagen Obtains Licenses to Real-Time PCR 27

Cepheid Purchases Sangtec 27

Source MDx Collaborates with Pfizer 27

Nanosphere Receives FDA Clearance for Second Molecular

Diagnostic Test 27

QIAGEN Acquires eGene 27

Quest Diagnostics Acquires AmeriPath 28

Mayo and ILMN Team up to Develop Molecular Diagnostics for

Complex- Diseases 28

CHEO and ILMN Team up to Develop Molecular Diagnostics for

Newborn Screening 28

Siemens Medical Solutions USA Sets Up Siemens Medical

Solutions Diagnostics 28

TMD Launches Test for K-ras Mutations in Colorectal Cancer

Patients 28

CombiMatrix Releases Updated Version of Constitutional Genetic

Array Test 29

Myriad Introduces TheraGuide 5-FU 29

CMDX Unveils First HemeScan(TM) Prognostic 29

CombiMatrix Introduces HemeScan(TM) MDS 29

8. MAJOR PLAYERS 30

Abbott Laboratories (US) 30

Abbott Molecular (US) 30

Applera Corporation (US) 30

Celera (US) 30

BioMerieux (France) 30

CytoCore Inc (US) 30

GE Healthcare (US) 31

Gen-Probe Inc (US) 31

Genzyme Corporation (US) 31

Genzyme Genetics (US) 31

MiraiBio, Inc. (US) 31

Nanogen (US) 31

Novartis Vaccines & Diagnostics, Inc. (US) 32

QIAGEN N.V (The Netherlands) 32

Quest Diagnostics, Inc. (USA) 32

Roche Diagnostics (Switzerland) 32

Siemens Healthcare Diagnostics (US) 32

Tecan Group Ltd. (Switzerland) 32

9. GLOBAL MARKET ANALYTICS 33

10. THE UNITED STATES 37

A Precursor to the Molecular Diagnostics Market in the US 37

Molecular Diagnostics Heavily Tied to Proteomics and Genomics 37

Burgeoning Potential for Genetic Testing 37

Regulatory Environment 38

Regulations Out for Molecular Diagnostic Testing of HPV 38

Limited Reimbursements - A Major Hindrance 39

11. CANADA 40

12. JAPAN 41

13. EUROPE 41

a. France 45

b. Germany 46

c. Italy 47

d. The United Kingdom 48

e. Rest of Europe 49

14. ASIA-PACIFIC 50

Indian Diagnostic Market 50

15. REST OF WORLD 51

EXHIBITS

Table 1: Percentage Breakdown of Worldwide In Vitro

Diagnostics (IVD) Market - 2006

Table 2: Percentage Breakdown of Leading Players in the

Worldwide In Vitro Diagnostics (IVD) Market - 2005

Table 3: Percentage Breakdown of Leading Players in the

Worldwide Molecular Diagnostics Market - 2006

Table 4: Percentage Breakdown of Leading Players in the

Worldwide Genetic Testing Market - 2006

Table 5: Percentage Breakdown of Worldwide Cancer Diagnostic

Testing Market - 2006

Table 6: Global Molecular Diagnostics Market by Region for

the Period 2007-2015 (Sales in US$ Million)

Table 7: Percentage Breakdown of Global Molecular Diagnostics

Market by Region for the Years 2008 & 2012

Table 8: Global Molecular Diagnostics (Infectious Disease

Testing) Market by Region for the Period 2007-2015 (Sales in

US$ Million)

Table 9: Percentage Breakdown of Global Molecular Diagnostics

(Infectious Disease Testing) Market by Region for the Years

2008 & 2012

Table 10: Global Molecular Diagnostics (Pharmacogenomics)

Market by Region for the Period 2007-2015 (Sales in US$

Million)

Table 11: Percentage Breakdown of Global Molecular Diagnostics

(Pharmacogenomics) Market by Region for the Years 2008 & 2012

Table 12: Global Molecular Diagnostics (Cancer Screening)

Market by Region for the Period 2007-2015 (Sales in US$

Million)

Table 13: Percentage Breakdown of Global Molecular Diagnostics

(Cancer Screening) Market by Region for the Years 2008 & 2012

Table 14: Molecular Diagnostics Market by Product Segment in

the US: 2007-2015 (Sales in US$ Million)

Table 15: Percentage Breakdown of Molecular Diagnostics Market

by Product Segment in the US for the Years 2008 & 2012

Table 16: Molecular Diagnostics Market by Product Segment in

Canada: 2007-2015 (Sales in US$ Million)

Table 17: Percentage Breakdown of Molecular Diagnostics Market

by Product Segment in Canada for the Years 2008 & 2012

Table 18: Molecular Diagnostics Market by Product Segment in

Japan: 2007-2015 (Sales in US$ Million)

Table 19: Percentage Breakdown of Molecular Diagnostics Market

by Product Segment in Japan for the Years 2008 & 2012

Table 20: Market Shares of Leading Players in the European

Molecular Diagnostics Market - 2006

Table 21: Molecular Diagnostics Market by Region in Europe:

2007-2015 (Sales in US$ Million)

Table 22: Percentage Breakdown of Molecular Diagnostics Market

by Region in Europe for the Years 2008 & 2012

Table 23: Molecular Diagnostics Market by Product Segment in

Europe: 2007-2015 (Sales in US$ Million)

Table 24: Percentage Breakdown of Molecular Diagnostics Market

by Product Segment in Europe for the Years 2008 & 2012

Table 25: Molecular Diagnostics Market by Product Segment in

France: 2007-2015 (Sales in US$ Million)

Table 26: Percentage Breakdown of Molecular Diagnostics Market

by Product Segment in France for the Years 2008 & 2012

Table 27: Molecular Diagnostics Market by Product Segment in

Germany: 2007-2015 (Sales in US$ Million)

Table 28: Percentage Breakdown of Molecular Diagnostics Market

by Product Segment in Germany for the Years 2008 & 2012

Table 29: Molecular Diagnostics Market by Product Segment in

Italy: 2007-2015 (Sales in US$ Million)

Table 30: Percentage Breakdown of Molecular Diagnostics Market

by Product Segment in Italy for the Years 2008 & 2012

Table 31: Molecular Diagnostics Market by Product Segment in

the UK: 2007-2015 (Sales in US$ Million)

Table 32: Percentage Breakdown of Molecular Diagnostics Market

by Product Segment in the UK for the Years 2008 & 2012

Table 33: Molecular Diagnostics Market by Product Segment in

Rest of Europe: 2007-2015 (Sales in US$ Million)

Table 34: Percentage Breakdown of Molecular Diagnostics Market

by Product Segment in Rest of Europe for the Years 2008 & 2012

Table 35: Molecular Diagnostics Market by Product Segment in

Asia-Pacific: 2007-2015 (Sales in US$ Million)

Table 36: Percentage Breakdown of Molecular Diagnostics Market

by Product Segment in Asia-Pacific for the Years 2008 & 2012

Table 37: Molecular Diagnostics Market by Product Segment in

Rest of World: 2007-2015 (Sales in US$ Million)

Table 38: Percentage Breakdown of Molecular Diagnostics Market

by Product Segment in Rest of World for the Years 2008 & 2012

COMPANIES PROFILED

To order this report:

Diagnostics Industry: Molecular Diagnostics - A World Market Review

More Market Research Report

Nicolas BombourgReportlinkerEmail: [email protected]: (805)652-2626Intl: +1 805-652-2626

SOURCE Reportlinker
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close